Benjamin Abramoff, MD
Physical Medicine & Rehabilitation · Philadelphia, PANPI 1992148118
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,850 of the $14,908 with a category attached, or 99.6%. 7 manufacturers reported payments, led by Modernatx, Inc. at 35.9% of the total. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 10 payments — averaging $1490.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$5K
- Pfizer$5K
- PTC Therapeutics, Inc.$2K
- Astrazeneca UK Limited$2K
- Biogen$1K
- Dentsply IH AB$45
- plus $13 from 1 others
What the payments were for
- Consulting fees$14,850100%
- Food & beverage$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1 | $5,350 |
| Pfizer | 4 | $5,050 |
| PTC Therapeutics, Inc. | 1 | $1,950 |
| Astrazeneca UK Limited | 1 | $1,500 |
| Biogen | 1 | $1,000 |
| Dentsply IH AB | 1 | $45 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moderna Covid-19 Vaccine$5,350
- PAXLOVID$2,250
How this compares
$14,908 in reported general payments places this provider in the 95th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.
See all physical medicine & rehabilitation providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 36 | $6,939 |
| Gabapentin | 74 | $1,478 |
| Lidocaine | 13 | $1,252 |
| Esomeprazole Magnesium | 14 | $1,138 |
| Baclofen | 39 | $789 |
| Tizanidine Hcl | 36 | $718 |
| Dantrolene Sodium | 15 | $679 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $586 |
| Pregabalin | 38 | $392 |
| Oxycodone Hcl | 41 | $318 |
| Duloxetine Hcl | 39 | $304 |
| Omeprazole | 15 | $207 |
| Nortriptyline Hcl | 12 | $185 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Philadelphia
- Alberto EsquenaziPhiladelphia$305K
- Kimberly HeckertPhiladelphia$119K
- Elaine HatchPhiladelphia$25K
- Ramesh GuptaPhiladelphia$14K
- Marisa MoretaPhiladelphia$13K
- M Quinn TatePhiladelphia$6K
- Benjamin KaplanPhiladelphia$5K
- Cameron OlezenePhiladelphia$4K
- Jeffery RoweKing Of Prussia$1.9M
- Michael SaulinoElkins Park$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.